Half, IF and I say IF he got a patent approved and it was licensed, yes it would increase the share price. I went on to explain the paticulars about the patent. It may not be a practical compound that is stabe and would NEVER be licensed just like the Constab compound.
Remember, the Constab Pharma compound does in fact work. It absolutely CURED some patients who had reached the end of all treatment and were terminal. This was fantastic IMO but the compound has to be manufactured and given to the patient within one HOUR after formumation. The sooner the better so that fact has prevented any major Pharma from getting involved.
Moro would be treating a patient via the RECAF receptor just like Constab. Would Moro's compund be stable? If not, it would NEVER be licensed.
I went on to explain how the patent life would be almost all gone by the time any Pharma got it on the market even if the compound was stable.
Granted, there is a possibility the patent would be approved but the odds of a patent even getting to market is very low.
You can dream all you want Half but reality for this stock appears to be cats and dogs and limited sales with Moro waiting to take it all with Pacific BioSciences if there were ever any significant sales.
I am not dream based Half, I am reality.
Market Data 
Markets 
AI
